Why is Onc going up?First of all! It is way underpriced.
They have two, phase 3 ready advancement possibilities.
one from stellar results alongside Roche ( tecentriq)....pancreatic cancer , FDA fast track approval
The other being results alongside Pfizer for MBC
Either or both could be ( and should be) in negotiations with Onc.
either licensing partnership, or total buy out.
It's very possible Roche would buy the whole thing, Run with the panc cancer & owning Onc, would allow them the same contract in existence with Pfizer...on the Mbc
when a company is bought, the new owners get it all. The A.N. Partnership, The Pfizer first right of refusal.
the Car-t , results that after a booster shot of Pela, eliminated the cancer.
if you look closely at Onc " pipeline" There are about a dozen different trials on going, with various institutions & pharma collaborations.
could be worth billions